Literature DB >> 23381523

Decision aids: when 'nudging' patients to make a particular choice is more ethical than balanced, nondirective content.

J S Blumenthal-Barby1, Scott B Cantor, Heidi Voelker Russell, Aanand D Naik, Robert J Volk.   

Abstract

Patient decision aids, such as instructional leaflets describing treatment options for prostate cancer, are designed to help educate patients so that they can share in decisions about their care. Developers of these decision aids strive for balance, aiming to be as neutral, unbiased, and nondirective as possible. We argue that balance should not always be a goal, and we identify three situations where it should not be. For example, men diagnosed with early-stage prostate cancer frequently are not advised by their physicians that active surveillance is a reasonable alternative to immediate surgery or radiation. It may be desirable to design decision aids that promote active surveillance as an option. We recognize that the arguments put forth in this article are controversial. But they are also justified. We challenge medical decision makers and decision aid developers to determine if and when patients should be "nudged" toward one option or another.

Entities:  

Mesh:

Year:  2013        PMID: 23381523     DOI: 10.1377/hlthaff.2012.0761

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  19 in total

1.  Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.

Authors:  Robert J Volk; Gianna T Kinsman; Yen-Chi L Le; Paul Swank; Jennifer Blumenthal-Barby; Stephanie L McFall; Theresa L Byrd; Patricia Dolan Mullen; Scott B Cantor
Journal:  J Health Commun       Date:  2015-06-11

2.  Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

Authors:  J S Blumenthal-Barby; Denise Lee; Robert J Volk
Journal:  CA Cancer J Clin       Date:  2015-05-21       Impact factor: 508.702

Review 3.  A standardized analysis of the current surgical and non-surgical treatment selection process for men with localized prostate cancer.

Authors:  Wenjie Zhong; Kayvan Haghighi; Prem Rathore; Eddy Wong; Pascal Mancuso
Journal:  J Robot Surg       Date:  2018-03-16

Review 4.  [Treatment of nonmetastatic prostate cancer: a systematic review of interactive, personalized patient decision aids].

Authors:  C Groeben; J C Streuli; T Krones; B Keck; M P Wirth; J Huber
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

5.  Potential Unintended Consequences Of Recent Shared Decision Making Policy Initiatives.

Authors:  Jennifer Blumenthal-Barby; Douglas J Opel; Neal W Dickert; Daniel B Kramer; Brownsyne Tucker Edmonds; Keren Ladin; Monica E Peek; Jeff Peppercorn; Jon Tilburt
Journal:  Health Aff (Millwood)       Date:  2019-11       Impact factor: 6.301

6.  Analysis of the Paternalistic Justification of an Agenda Setting Public Health Policy: The Case of Tobacco Plain Packaging.

Authors:  Thomas Boysen Anker
Journal:  Public Health Ethics       Date:  2016-05-30       Impact factor: 1.940

7.  Shared Decision Making in Patients With Suspected Uncomplicated Ureterolithiasis: A Decision Aid Development Study.

Authors:  Elizabeth M Schoenfeld; Connor Houghton; Pooja M Patel; Leanora W Merwin; Kye P Poronsky; Anna L Caroll; Carol Sánchez Santana; Maggie Breslin; Charles D Scales; Peter K Lindenauer; Kathleen M Mazor; Erik P Hess
Journal:  Acad Emerg Med       Date:  2020-02-16       Impact factor: 3.451

8.  The effect of urologist experience on choosing active surveillance for prostate cancer.

Authors:  William G Chu; Brian J Kim; Jeff Slezak; Teresa N Harrison; Joy Gelfond; Steven J Jacobsen; Gary W Chien
Journal:  World J Urol       Date:  2015-03-12       Impact factor: 4.226

9.  Decision aids for organ transplant candidates.

Authors:  Elisa J Gordon; Michael G Ison
Journal:  Liver Transpl       Date:  2014-07       Impact factor: 5.799

Review 10.  Bending the Cost Curve in Childhood Cancer.

Authors:  Heidi Russell; M Brooke Bernhardt
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.